This research report on the global medical linear accelerator market covers sizing and forecast, share, industry trends, growth drivers, and vendor analysis. The study includes insights by Products (equipment and software), Application (breast cancer, prostate cancer, lung cancer, head and neck cancer, colorectal cancer and others), End-users (hospitals, cancer care centers, and academic institutes and research centers), and Geography (North America, APAC, Europe, Latin America, and MEA).
The growing prevalence of cancer worldwide, coupled with rapid technological advancements and increased healthcare expenditure, is expected to boost the market growth. Linear accelerators (LINAC) are considered as breakthrough devices, which have revolutionized treatment due to their cost-effectiveness. Further, the market has witnessed a significant shift in cancer treatment delivery with increasing preference from invasive to non-invasive treatment procedures. As non-invasive treatment includes radiation therapy, which is the most advanced and cost-effective treatment option for patients. It helps to treat a wide range of cancers and could be used alone or in conjunction with surgery, chemotherapy, and other treatment procedures. Therefore, this phenomenal shift in consumer expectation has increased the acceptance of medical LINAC equipment.
Further, the continuous focus of vendors on technological advances and improvements has led to several breakthroughs and disruptive medical linear accelerator market. The market has witnessed the launch of several advanced and innovative devices for oncological treatment and observed major changes in terms of product design, material usage, and radiotherapy techniques, which facilitated medical professionals to perform cancer treatment efficiently.
The emergence of artificial intelligence is revolutionizing the medical imaging devices market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming cancer treatment using LINAC devices. Hence, vendors are focusing on developing AI and ML-enabled LINACs for oncology treatment, which is likely to become convenient treatment options in upcoming years.
The global medical linear accelerator market is growing at a CAGR of over 7% during the forecast period 2019–2025.
This research report includes detailed segmentation by product, application, end-user, and geography.
The rapid use of radiotherapy with medical linear accelerator equipment for the treatment of breast cancer, along with the growing incidence of these cases, is responsible for the segment growth. With the increasing prevalence of breast cancers, the demand for advanced treatment options such as radiotherapy devices is expected to grow as they are highly targeted and effective in destroying the malignant cells.
The prostate segment is likely to grow at a promising CAGR during the forecast period. The primary factor driving growth includes the rise in prostate cancer worldwide. As radiation therapy is used as a curative treatment, the usage of medical LINAC devices for prostate cancer treatment is likely to increase. Further, the rise in the geriatric population worldwide is another key factor driving the market.
Lung cancer treatment is projected to achieve maximum revenue owing to the rapid rise across the globe. Hence, the application of radiation therapy with LINAC for these treatments is likely to gain a lucrative share in the market. The increasing application of external beam radiation therapy (EBRT) is driving prominent vendors to offer advanced LINAC systems for lung cancer treatments.
The availability of other treatment options, including brachytherapy, internal radiotherapy, combined radiation, and chemotherapy, is offering effective treatment for head & neck cancer treatment, thereby contributing to the slow but steady growth rate. However, the high growth in these cases, coupled with the use of modern linear accelerators, is projected to drive market growth.
The medical linear accelerator equipment segment is growing due to the growing incidence of cancers globally, coupled with the increasing demand for digitally advanced radiotherapy devices. The use of innovative oncology informatics platforms has led to rapid progress in radiation treatment planning, thereby saving time and cost. The demand for integration of digital solutions with LINAC is increasing as oncology informatics helps in better planning for radiotherapy and improves the effectiveness and patient outcomes in cancer care. The integration of informatics/software with radiation oncology is changing the treatment dynamics by providing end-users with smart and efficient tools to help receive, transmit, and store electronic information flawlessly.
The hospitals segment is likely to dominate the global medical linear accelerator market; however, the cancer care center segment is projected to grow at the highest CAGR during the forecast period. The adoption of advanced radiotherapy devices such as LINAC is high, as majority of patients prefer to visit hospitals for cancer treatment because they offer advanced radiotherapy infrastructure facilities.
The academic institute & research centers segment is growing at a healthy rate due to the availability of advanced radiotherapy techniques such as 3D, 4D and Intensity-modulated radiation therapy (IMRT), external beam radiation therapy (EBRT), Image-guided radiation therapy (IGRT), and magnetic resonance (MR) linear accelerator therapy. Moreover, the increasing number of cancer cases globally is another factor driving the growth of the segment.
North America is growing at a significant rate due to the growing preference for technologically advanced medical LINAC devices. The presence of a large pool of the patient population requiring radiotherapy, coupled with high acceptance of innovative devices and high awareness of non-invasive treatments, has collectively driven the North America market.
Germany, France, the UK, Spain, and Italy are the major revenue contributors in Europe. The presence of highly sophisticated healthcare infrastructure, along with the high awareness of advanced oncology treatment, is increasing the demand for innovative radiotherapy devices. The APAC market is expected to witness the highest absolute growth during the forecast period. The region has the largest population density and the highest proportion of people with cancers. China, Japan, India, Australia, and South Korea are the major revenue contributors from the region. Brazil, Mexico, and Argentina are the major revenue contributors to the medical linear accelerator market in Latin America. Although the market is growing at a moderate rate, it offers tremendous growth opportunities. Therefore, the growing need for efficient and high-quality medical care is likely to drive the market in Latin America. Turkey, Saudi Arabia, and South Africa are the major revenue contributors to the MEA market.
Key Vendor Analysis
The global market has only six vendors that provide medical linear accelerator equipment at the global and regional levels. The market is highly consolidated as the leading two vendors account for around 89% of the market share.
The market is witnessing rapid technological advancements and product launches. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers are continuously focusing on product development and offering advanced technology-enabled medical linear accelerator devices.
Other Prominent Vendors – SHINVA MEDICAL INSTRUMENT, Panacea Medical Technologies, and ViewRay Technologies
Key Market Insights
The report provides the following insights into the medical linear accelerator market for the forecast period 2019–2025.
Get the updated report free if published within 100 days of purchase
Free datasheet worth $1500 with team and corporate license.
10% free customization. Speak to our analyst